Iyo Bank Ltd. Takes Position in Danaher Corporation $DHR

Iyo Bank Ltd. bought a new position in Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 4,328 shares of the conglomerate’s stock, valued at approximately $3,116,000. Danaher comprises 0.9% of Iyo Bank Ltd.’s portfolio, making the stock its 28th biggest position.

Other hedge funds also recently added to or reduced their stakes in the company. Main Street Group LTD purchased a new stake in Danaher in the 1st quarter worth about $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher during the second quarter valued at approximately $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher during the third quarter valued at approximately $25,000. WFA of San Diego LLC bought a new position in shares of Danaher during the second quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in shares of Danaher in the fourth quarter worth approximately $27,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Performance

Danaher stock opened at $219.42 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a market capitalization of $154.25 billion, a PE ratio of 38.97, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a 50 day moving average price of $195.80 and a 200-day moving average price of $192.61. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.77 earnings per share. As a group, equities analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Citigroup assumed coverage on Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. Guggenheim cut their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Piper Sandler assumed coverage on Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. Wells Fargo & Company decreased their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Finally, Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.